社区

* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22 - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of

Major retailers including Walmart(WMT) and Target(TGT) have substantial opportunities to grow the sa

Summary With inflation running its hottest course in 40 years, the Federal Reserve has decided to a

The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5

- Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S

Hey Tigers! Do you notice Pfizer's new play? Pfizer announced its acquisition of Arena Pharmaceuticals today in a $6.7 billion deal for the company’s research on inflammatory conditions affecting the stomach and intestine. Pfizer will pay Arena $100/share in cash. Shares of Arena stock nearly doubled yesterday as the company pursues treatments for ulcerative colitis and Crohn’s disease, as well as other dermatological, gastrointestinal, and cardiac conditions — Arena’s etrasimod drug for ulcerative colitis/Crohn’s is currently in late-stage trials. The acquisition’s timing is no coincidence as Pfizer also investigates treatments for gastrointestinal conditions. Pfizer is on a roll, lately. In addition to the o

现在不光蔬菜，猪肉涨价，居然连烟都要涨价了！前几天在全国控烟学术研讨会上，有专家说为了实现2030年成人的吸烟率下降到20%的控烟目标，烟的价格需要涨到平均每包59块。现在的价格是平均16块，还有43块钱的上涨空间。而且专家也列出了一些相关数据，首先我国不仅是最大的烟草生产国，同时也是最大的消费国，烟草的消费量世界第一，占比44%。烟民的数量超过了3亿，而且还有7.4亿人受二手烟的危害，同时有大约四分之一的癌症死亡是与吸烟相关的。那相应的，抽烟带来的疾病就会增加国家的医疗支出负担。所以为了降低吸烟率，16年国家就提出了“健康中国2030”目标，里面最首要的就是控烟目标，把成人的吸烟率下降到20%。要知道我国的吸烟率从84年的33.9%下降到18年的26.6%，可是足足花了34年，但最近几年呢吸烟率却有不降反升的趋势，如果后期再不采取其他措施的话，等于前面四五年的工作就都浪费掉了，从会议的讨论结果来看，到2030年每包烟的平均价格可能要从现在的16块钱一包提高到59块钱，除此之外还有一些非价格的控烟措施，比如室内不准抽烟，理发监督保障等等，还有以后烟盒可能要参考国外那种非常“露骨的”方式。最后给提醒一下大家，国外机构做了戒烟年龄和肺癌风险的研究，结论是哪怕你现在是60岁的烟民，从现在开始戒烟，得肺癌的风险也会大大降低，都说抽烟难借，但为了自己和家人的身体健康还是早戒早好。$陕西金叶(000812)$ $劲嘉股份(002191)$